CAR T-Cell Immunotherapy Induces Finish Remissions in Patients with Refractory DLBCL Date: nine Dec 2016 Topic: Haematologic malignancies / Cancer Immunology and Immunotherapy A late violating abstract introduced during the 58th American Society of Haematology (ASH) Annual Meeting and Exposition in San Diego, US (3-6 […]